How Avastin May Affect Your Cancer
Avastin is a first-of-its-kind cancer therapy that is approved with carboplatin and paclitaxel (chemotherapy) to help you live longer. This combination of treatments provides 2 distinct ways of attacking your cancer. Carboplatin and paclitaxel (chemotherapy) work by attempting to destroy cancer cells by stopping them from growing or dividing. Avastin works by starving the tumor of what it needs to grow and spread. Because Avastin and carboplatin and paclitaxel (chemotherapy) attack cancer in different ways, they are given together for a combined fight to help control your cancer and extend survival.
On average, people in clinical trials receiving Avastin plus carboplatin and paclitaxel (chemotherapy) were more likely to
- Live longer than those who received carboplatin and paclitaxel (chemotherapy) alone
- Have a longer time before their tumors grew than those who received carboplatin and paclitaxel (chemotherapy) alone
These benefits were seen when Avastin was continued for as long as the disease was controlled, or until side effects became unmanageable.
While people benefited from combined treatment with Avastin plus carboplatin and paclitaxel (chemotherapy), there were also some side effects because both therapies may affect normal cells. It is important that you discuss with your health care team how to manage these or any other side effects of your cancer treatment.
What is the safety information for Avastin in advanced NSCLC?
In the advanced non-small cell lung cancer trial, the most common life-threatening to fatal side effects that increased by 2% or more in people who received Avastin vs those in the comparison group were reduced white blood cell counts (27% vs 17%), tiredness (16% vs 13%), high blood pressure (8% vs 0.7%), infection without reduced white blood cell counts (7% vs 3%), blood clots in the veins of the body (5% vs 3%), fever with reduced white blood cell counts (5% vs 2%), inflammation of the lungs (5% vs 3%), infection with severe or life-threatening reduced white blood cell counts (4% vs 2%), low sodium levels in the blood that could lead to seizure or coma (4% vs 1%), headache (3% vs 1%), and too much protein in the urine (3% vs 0%).